Source comparison
GHRP-2 vs Ipamorelin: Half-Life and Timing
A practical difference in the GHRP-2 vs Ipamorelin comparison that impacts protocol design: half-life. GHRP-2 has a half-life of approximately 30 minutes, producing a sharp, brief GH pulse. Ipamorelin has a significantly longer half-life (~2 hours), producing
This comparison does not assign a generated winner or score.
- A practical difference in the GHRP-2 vs Ipamorelin comparison that impacts protocol design: half-life. GHRP-2 has a half-life of approximately 30 minutes, producing a sharp, brief GH pulse. Ipamorelin has a significantly longer half-life (~2 hours), producing a more sustained GH elevation. In the GHRP-2 vs Ipamorelin comparison, this timing difference affects how each compound pairs with measurement endpoints and diurnal GH physiology.
- For research requiring acute, precisely-timed GH pulses (e.g., GH stimulation testing, peak GH measurement), GHRP-2’s rapid kinetics provide a cleaner pharmacokinetic signal. For research requiring sustained GH elevation (e.g., body composition effects over hours, sleep-period GH augmentation), Ipamorelin’s extended duration provides more overlap with the biological window of interest. The GHRP-2 vs Ipamorelin half-life difference is often the underappreciated factor that determines which compound is the better fit for a specific experimental design.